The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin.
about
Natural biology and management of nonmuscle invasive bladder cancer.Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway.Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patients.Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer.CUA guidelines on the management of non-muscle invasive bladder cancer.Results of second transurethral resection for high-grade T1 bladder cancer.Prognostic Factors for Recurrence and Progression in Korean Non-Muscle-Invasive Bladder Cancer Patients: A Retrospective, Multi-Institutional StudyPTTG1 regulated by miR-146a-3p promotes bladder cancer migration, invasion, metastasis and growth.Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.Second-look resection for primary stage T1 bladder cancer: a population-based study.New developments in the management of nonmuscle invasive bladder cancer.Guideline of guidelines: non-muscle-invasive bladder cancer.BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG.What is new in non-muscle-invasive bladder cancer in 2016?Tackling non-muscle invasive bladder cancer in the clinic.Is restaging transurethral resection necessary in patients with non-muscle invasive bladder cancer and limited lamina propria invasion?A 10-Item Checklist Improves Reporting of Critical Procedural Elements during Transurethral Resection of Bladder Tumor.Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Guérin.Carcinoma in situ is significantly underdetected by prenephroureterectomy ureteroscopy in the management of upper tract urothelial cancersOncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer.The role of LIM and SH3 protein-1 in bladder cancer metastasis.Dose, duration and strain of bacillus Calmette-Guerin in the treatment of nonmuscle invasive bladder cancer: Meta-analysis of randomized clinical trials.Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer.Astrocyte elevated gene-1 promotes invasion and epithelial-mesenchymal transition in bladder cancer cells through activation of signal transducer and activator of transcription 3.Cell-penetrating peptide conjugates of gambogic acid enhance the antitumor effect on human bladder cancer EJ cells through ROS-mediated apoptosis.Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients
P2860
Q33561637-416BC4C0-BFCF-43BD-8870-348D79F3BE78Q33566847-76927137-3085-485D-889C-6BFC309041A0Q35677853-44D79ACE-F7E3-41A3-BFD5-510EB54E2A20Q35937807-048AAB85-CB06-41BD-AA05-AE27A0D2C8FCQ36326208-7B35711B-5033-45E6-86B4-5FFA399F94D5Q36481219-E78E453F-7797-4AA6-A197-691A981C9ED7Q37110153-3D2D1619-EFDC-487C-A72D-03780127E1EDQ37702335-219DF543-2B86-48D5-87FB-3FEF1392DCF7Q38253205-D05D3DC7-663C-4D25-B0AE-F36A11BB8D9AQ38842782-E75FB238-934F-4992-8943-3B73B6F625B1Q38914895-4A011B75-8C68-45D8-BFF1-56172434F9AAQ39069660-F49FACC9-7D42-435B-9680-10F0D7C25960Q39156389-5497F539-7764-47B3-9179-1376374949F1Q39167317-4030F30C-F90A-49DF-B751-B3B54EE7D35CQ39209020-0FE5AB91-4516-43C1-AFB0-C563633230F2Q40130355-4CB7538A-6CAA-42CD-B1B6-0C792079D7BCQ40818129-5857D420-6DE8-470E-A606-B7E655E7ACC1Q41348953-24FD16A2-9F35-4EEC-89D5-0899EE8CE414Q41836655-14762619-4A84-46E7-BAD8-C5997634440BQ43875491-3AF71F5F-4CFC-44A3-836C-F8B802A895BDQ47139274-6E6AB378-B8FB-4896-A705-C18EC8C4AF58Q47155382-62B18D09-30E0-4370-854D-F6B2E7DEA0A8Q49239026-994C8CB9-780B-4F05-8742-AFC2E424BF95Q50104714-061BBE41-A762-43DC-A26E-F91590C4CA37Q55009922-EA949E09-35B1-405A-971F-C9BAF2CF365DQ58705101-AC14B2C7-31AD-463B-976E-E257BE48E5DC
P2860
The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The effect of restaging transu ...... ical bacillus Calmette-Guérin.
@ast
The effect of restaging transu ...... ical bacillus Calmette-Guérin.
@en
The effect of restaging transu ...... ical bacillus Calmette-Guérin.
@nl
type
label
The effect of restaging transu ...... ical bacillus Calmette-Guérin.
@ast
The effect of restaging transu ...... ical bacillus Calmette-Guérin.
@en
The effect of restaging transu ...... ical bacillus Calmette-Guérin.
@nl
prefLabel
The effect of restaging transu ...... ical bacillus Calmette-Guérin.
@ast
The effect of restaging transu ...... ical bacillus Calmette-Guérin.
@en
The effect of restaging transu ...... ical bacillus Calmette-Guérin.
@nl
P2093
P2860
P1476
The effect of restaging transu ...... ical bacillus Calmette-Guérin.
@en
P2093
A Ari Hakimi
Harry W Herr
John P Sfakianos
Philip H Kim
P2860
P304
P356
10.1016/J.JURO.2013.08.022
P407
P577
2013-08-20T00:00:00Z